MedTrace Logo

Imaging Inflammation in Autoimmune Diabetes

NCT00585936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2011-11-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether magnetic resonance imaging (MRI) with ferumoxtran-10 can be used to detect changes in the pancreas associated with autoimmune diabetes.

Conditions

  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • AMAG Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Joslin Diabetes Center

    lead OTHER

Principal Investigators

  • Richard A Jackson, M.D. · Joslin Diabetes Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585936 on ClinicalTrials.gov